arrow
S

Seung Hun Jang

Hallym University
H指数:29
被引数:2,563

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic factors affecting mortality in elderly, low body mass index, and poor performance status groups with lung cancer: analysis of the 2016 Korean Association of Lung Cancer Registry (KALC-R) database

影响老年、低体重指数及较差体能状态肺癌患者死亡率的预后因素:韩国肺癌登记系统(KALC-R)2016年数据库分析

2025-09-300
PRE
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial

Bojungikki-Tang草药 medicine 联合 Pembrolizumab 与 Pembrolizumab 单药治疗对 IV 期非小细胞肺癌的疗效与安全性:一项随机、开放标签、双臂、多中心试验的研究方案

2025-02-220
OA
Factors Associated with Postoperative Recurrence in Stage I to IIIA Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: Analysis of Korean National Population Data

表皮生长因子受体突变相关的Ⅰ期至ⅢA期非小细胞肺癌术后复发相关因素:基于韩国全国人口数据的分析

2025-01-151
OA
Sex Differences in Chronic Cough Epidemiology: The Korean Cough Study Group

慢性咳嗽流行病学的性别差异: 韩国咳嗽研究小组

2024-01-010
OAAI
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors

EGFR突变非小细胞肺癌脑转移患者一线阿法替尼的真实世界分析: 生存和预后因素

2023-06-012
OAAI
Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

在韩国2型糖尿病患者中,钠-葡萄糖协同转运蛋白2抑制剂与二肽基肽酶4抑制剂与呼吸不良事件的相关性: 一项全国性队列研究

2023-02-1016
OAAI